Vidwan-ID : 339334

Edit Profile

    Score criteria

Criteria Point
Personal Details 1
Expertise Details 1
Experience Details 1
Qualification Details 1
Employee ID 0.2
Orcid ID 0.2
Researcher ID 0.2
Scopus ID 0.2
Google Scholar ID 0.2
Honours <=3< /td> 0.3
Honours >3 0.5
Project worth less than Rs.5,00,000/- 0.2
Project worth more than Rs.5,00,000/- 0.5
Membership in professional Bodies < 5 0.5
Membership in professional bodies >=5 1
No of publications <=15 1
No of publications between 15-45 2
No of publications >45 3

Vidwan Score 8.2

82% Complete
11 Articles
1 Projects
1 Awards

Dr Tom Skaria

Assistant Professor (Grade-I)
National Institute of Technology, Calicut

Publications

  • 11
    Journal Articles
  • 1
    Projects
  • 1
    Awards
  • 10
  • 1
  • 3
  • 1

Citations / H-Index

193 Citations
8 h-index
156 Citations


Google Scholar


Co-author Network


Expertise

Immunology

Inflammation, Cytokine Signaling, Cardiovascular Drug Targets

Personal Information

Dr Tom Skaria

1984 Male
School Of Biotechnology National Institute Of Technology Calicut
, Kerala, India - 673601


Experience in Months

Academic: 10 Administrative: 0 Industry: 0

Experience

  • Assistant Professor (Grade-I)

    School of Biotechnology

    National Institute of Technology, Calicut, Kozhikode

  • Post-Doctoral Research Scientist

    Medicine

    University of Zurich, Switzerland


Qualification

  • Ph.D.

    University of Zurich, Switzerland

  • M.S.

    University of Skövde, Sweden.

  • M.Sc.

    Bangalore University


Honours and Awards

2019

ESC Young Researcher Travel Award

European Society of Cardiology

2019

ESC Young Researcher Travel Award

European Society of Cardiology

Read Less

Membership In Professional Bodies

2021

Indian Immunology Society

Life time member

2021

Indian Immunology Society

Life time member

Read Less

Research Projects

Cathepsin-S as a novel direct drug target for preventing barrier and tissue destructive proinflammatory IL-1 beta signaling in primary, vascular endothelium: an in vitro study

Funding Agency : DST SERB

Cathepsin-S as a novel direct drug target for preventing barrier and tissue destructive proinflammatory IL-1 beta signaling in primary, vascular endothelium: an in vitro study

Funding Agency : DST SERB

Read Less

Publications (16)